NatashaDolginMDPhD

Public Health & General Preventive Medicine, Addiction Medicine

Medical Director, Substance Use

Dr. Dolgin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Cook County Health and Hospitals System/Northwestern Feinberg School of MedicineResidency, Public Health and General Preventive Medicine, 2020 - 2022
University of Massachusetts Medical SchoolClass of 2017

IL State Medical License 2020 - 2026
IN State Medical License 2024 - 2025
MA State Medical License 2017 - 2020
American Board of Preventive Medicine Public Health & General Preventive Medicine

PubMed

6 citations
Single-Center Experience With Liver Transplant Using Donors With Very High Transaminase Levels.
Paulo N. Martins, Amanda Rawson, Babak Movahedi, Isabel M A Brüggenwirth, Natasha H. Dolgin
Experimental and Clinical Transplantation. 2019-08-01
57 citations
Functional status predicts postoperative mortality after liver transplantation.
Natasha H. Dolgin, Paulo N. Martins, Babak Movahedi, Kate L. Lapane, Frederick A. Anderson
Clinical Transplantation. 2016-11-01
10 citations
Donor Diabetes and Prolonged Cold Ischemia Time Synergistically Increase the Risk of Graft Failure After Liver Transplantation.
Isabel M A Brüggenwirth, Natasha H. Dolgin, Robert J. Porte, Adel Bozorgzadeh, Paulo N. Martins
Transplantation Direct. 2017-06-12